Skip to main content

and
  1. Article

    Open Access

    Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers

    CTCs have extensively been used for the monitoring and characterization of metastatic prostate cancer, but their application in the clinic is still very scarce. Besides, the resistance mechanisms linked to pro...

    Thais Pereira-Veiga, Miriam González-Conde in Clinical & Experimental Metastasis (2021)

  2. Article

    Open Access

    Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

    Pazopanib is indicated in the first-line treatment of metastatic renal cell cancer (mRCC). The aim of this study was to review the efficacy, safety, and pharmacokinetics of pazopanib and see how these aspects ...

    María José Méndez-Vidal, Áurea Molina, Urbano Anido in BMC Pharmacology and Toxicology (2018)

  3. No Access

    Article

    Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU)

    Once metastatic bladder cancer has progressed to first-line treatment, the number of therapeutic options is scarce. Among chemotherapeutic agents showing activity in phase II trials, including taxanes, vinflun...

    Jorge García, Lucia Santomé, Urbano Anido in Current Oncology Reports (2016)

  4. Article

    Open Access

    Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial

    Renal angiomyolipomas (AML) are usual manifestations of tuberous sclerosis complex (TSC) that may cause aneurism-related haemorrhages and renal impairment. Everolimus has emerged as an alternative to surgery/e...

    Nicolás Roberto Robles, Ramón Peces in Orphanet Journal of Rare Diseases (2016)

  5. No Access

    Article

    The Wide Experience of the Sequential Therapy for Patients with Metastatic Renal Cell Carcinoma

    Sequential targeted therapies are the standard of care for patients with metastatic renal cell carcinoma (mRCC). Several drugs are available for patients whose disease progresses while they receive initial tyr...

    Julio Lambea, Urbano Anido, Olatz Etxániz, Luis Flores in Current Oncology Reports (2016)

  6. No Access

    Article

    Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: results of a pilot study

    Background The objectives of this pilot study were to evaluate the safety and efficacy of the central nervous system stimulant methylphenidate in the management of asthenia in breast cancer patie...

    Juan F. Cueva, Marcos Calvo, Urbano Anido, Luis León in Investigational New Drugs (2012)